Literature DB >> 12657115

Polymorphism at the -308-promoter position of the tumor necrosis factor-alpha (TNF-alpha) gene and cervical cancer.

G A Stanczuk1, E N Sibanda, S A Tswana, S Bergstrom.   

Abstract

The purpose of the study was to investigate the hypothesis that the genetically programmed ability to produce low, medium, or high levels of tumor necrosis factor-alpha (TNF-alpha), as determined by TNF-alpha promoter polymorphism at position 308, influenced the development of cancer of the uterine cervix. The population was recruited from patients attending gynecological clinics at two teaching hospitals in Harare, Zimbabwe. Laboratory tests were performed in the Departments of Immunology and Medical Microbiology, Medical School, University of Zimbabwe. One hundred and three patients with invasive cancer of the uterine cervix and 101 healthy women were included in the study. All patients and healthy controls were from the Shona ethnic groups that inhabit northern Zimbabwe. DNA was purified from cervical cytobrush samples obtained from women with cervical cancer. In random cases a second DNA sample was extracted from patient blood. Control DNA was extracted from urine or peripheral blood samples from the healthy women. Detection of allele A and /or G at the 308 position in the promoter region of the TNF-alpha gene was carried out using the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) technique. Polymorphism in the amplified products was detected by gel electrophoresis. There was no statistically significant difference in the distribution of the low (G) or high (A) producer alleles at position 308 of the TNF-alpha gene between patients with cervical cancer and healthy women. The high producer haplotype AA was identified in only one patient with cervical cancer and two healthy women. These data suggest that the genetically acquired ability to produce higher levels of TNF-alpha is present in a minority of women with or without cervical cancer in the Zimbabwean population. Homozygosity for allele 308A is very rare. High-producer allele 308A as well as high-producer haplotypes AA is significantly less common in a Zimbabwean population than in a European population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657115     DOI: 10.1046/j.1525-1438.2003.13046.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  15 in total

1.  TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk.

Authors:  Gisela Barbisan; Luis Orlando Pérez; Anahí Contreras; Carlos Daniel Golijow
Journal:  Tumour Biol       Date:  2012-05-17

2.  Association between tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical cancer.

Authors:  Lanling Wang; Kunpeng Ma; Zhiyong Wang; Yingying Mou; Li Ma; Yong Guo
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Tumor Necrosis Factor Alpha (-238 / -308) and TNFRII-VNTR (-322) Polymorphisms as Genetic Biomarkers of Susceptibility to Develop Cervical Cancer Among Tunisians.

Authors:  Sabrina Zidi; Mouna Stayoussef; Ferjeni Zouidi; Samir Benali; Ezzedine Gazouani; Amel Mezlini; Besma Yacoubi-Loueslati
Journal:  Pathol Oncol Res       Date:  2014-08-12       Impact factor: 3.201

4.  Association of a variant in the tumor necrosis factor alpha gene with risk of cervical cancer.

Authors:  Negin Behboodi; Marjaneh Farazestanian; Azam Rastgar-Moghadam; Ehsan Karimi; Majid Rajabian; Mehrane Mehramiz; Farzad Rahmani; Shadi Khorrami; Amirhosein Jafarian; Noorieh Sharifi-Sistani; Gordon A Ferns; Amir Avan; Malihe Hasanzadeh
Journal:  Mol Biol Rep       Date:  2021-02-08       Impact factor: 2.316

5.  TNF-α -308 G/A as a risk marker of cervical cancer progression in the Polish population.

Authors:  Andrzej Roszak; Matthew Misztal; Anna Sowińska; Paweł P Jagodziński
Journal:  Mol Diagn Ther       Date:  2015-02       Impact factor: 4.074

6.  A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer.

Authors:  Hua-Lian Zhang; Yi-Jie Zhang
Journal:  Tumour Biol       Date:  2013-03-15

7.  Interleukin-1 beta-511 polymorphism and risk of cervical cancer.

Authors:  Sokbom Kang; Jae Weon Kim; Noh Hyun Park; Yong Sang Song; Sang Yoon Park; Soon Beom Kang; Hyo Pyo Lee
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

8.  Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysis.

Authors:  Li Liu; Xi Yang; Xiaojun Chen; Tinjing Kan; Yan Shen; Zengyan Chen; Zhibin Hu
Journal:  Mol Biol Rep       Date:  2011-06-14       Impact factor: 2.316

9.  TNF-alpha rs1800629 polymorphism is not associated with HPV infection or cervical cancer in the Chinese population.

Authors:  Ning Wang; Duo Yin; Shulan Zhang; Heng Wei; Shizhuo Wang; Yang Zhang; Yanming Lu; Shuyan Dai; Wei Li; Qiao Zhang; Yao Zhang
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

10.  Genetic susceptibility of cervical cancer.

Authors:  Xiaojun Chen; Jie Jiang; Hongbing Shen; Zhibin Hu
Journal:  J Biomed Res       Date:  2011-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.